RightFit Trial Directory

Parkinson's Disease clinical trials in Stamford, CT

4 recruiting parkinson's disease studies with a site in Stamford, CT.

All trials in Stamford, CT · All Parkinson's Disease trials

RecruitingPhase 3NCT06345729

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Sponsor: Merck Sharp & Dohme LLC

Stamford, CT · +14 more sites

RecruitingPhase 3NCT06312176

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Sponsor: Merck Sharp & Dohme LLC

New Haven, CT · Stamford, CT · +44 more sites

RecruitingPhase 2 / Phase 3NCT07284784

A Study of Buntanetap in Participants With PD

Sponsor: Annovis Bio Inc.

Stamford, CT · +26 more sites

RecruitingPhase 2NCT07804615

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

Sponsor: Vima Therapeutics

Stamford, CT · +28 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.